Effects of Calcium Blockers on the Cytosolic Calcium, H2O2Production and Elastase Release in Human Neutrophils
- 1 December 1996
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 79 (6) , 312-317
- https://doi.org/10.1111/j.1600-0773.1996.tb00015.x
Abstract
Activated neutrophils are assumed to be one plausible cause of tissue injury in the ischaemic and reperfused myocardium. We studied the inhibitory effects of the calcium antagonists felodipine, nimodipine and verapamil on human neutrophil activation in order to elucidate the mechanisms underlying their myocardioprotective effects and to determine whether calcium antagonists with different chemical structures vary in their effect on neutrophil activation. Neutrophils were stimulated with formyl‐Met‐Leu‐Phe (0.1 μM) or by phorbol myristate acetate (0.16 μM), and the rise in cytosolic calcium and the H2O2production were determined. For felodipine, the inhibitory effect on granulocyte elastase release was also studied. The calcium antagonists reduced formyl‐Met‐Leu‐Phe and phorbol myristate acetate‐induced neutrophil activation in a concentration‐dependent manner, the order of potency being: felodipine >nimodipine >verapamil. For felodipine, the IC50(concentration causing 50% reduction) values were 3×10−6and 2×10−6M for the formyl‐Met‐Leu‐Phe‐induced cytosolic calcium increase and H2O2production, respectively. The IC50‐value for the phorbol myristate acetate‐induced cytosolic calcium increase was 6×10−6and for H2O2production 4×10−6M. For formyl‐Met‐Leu‐Phe‐induced granulocyte elastase release, the IC50‐value was 5×10−6M. The inhibitory effect of felodipine on the phorbol myristate acetate‐induced granulocyte elastase release did not exceed 50%. Nimodipine was a less potent inhibitor than felodipine for both formyl‐Met‐Leu‐Phe‐ and phorbol myristate acetate‐induced cell activities. Verapamil was even less potent than the other two agents. The present study demonstrates that felodipine potentially suppresses neutrophil activation at micromolar concentrations. However, this observation should not be directly extrapolated to explain the tissue protection by the compounds without evidence of profound local accumulation.Keywords
This publication has 27 references indexed in Scilit:
- Ischemic and Nonischemic Tissue Concentrations of Felodipine After Coronary Venous Retroinfusion During Myocardial Ischemia and ReperfusionJournal of Cardiovascular Pharmacology, 1994
- Coronary Venous Retroinfusion of Felodipine Reduces Myocardial Necrosis After Coronary Occlusion and ReperfusionJournal of Cardiovascular Pharmacology, 1993
- Acute Haemodynamic Effects of Felodipine, Verapamil and Hydralazine in the Anaesthetized DogBasic & Clinical Pharmacology & Toxicology, 1991
- Myocardial ischemia, reperfusion and free radical injuryThe American Journal of Cardiology, 1990
- Local and global changes in cytosolic free calcium in neutrophils during chemotaxis and phagocytosisCell Calcium, 1990
- Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.Journal of Clinical Investigation, 1988
- Enhancement of salvage of reperfused ischemic myocardium by diltiazemJournal of the American College of Cardiology, 1986
- Aequorin detects increased cytoplasmic calcium in platelets stimulated with phorbol ester or diacylglycerolBiochemical and Biophysical Research Communications, 1985
- The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts.Circulation, 1984
- Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation, 1983